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The outcome of chronic viral infections, which affect
millions of people worldwide, is greatly dependent
on CD4+ T cells. Here we showed that T cell-specific
ablation of the common interleukin-6 (IL-6) family
receptor, gp130, profoundly compromised virus-
specific CD4+ T cell survival, T follicular helper re-
sponses, and IL-21 production at late stages of
chronic lymphocytic choriomeningitis virus (LCMV)
infection. These effects were cell intrinsic for CD4+
T cells and were accompanied by a reduction of
CD8+ T cells, antibodies, and a severe failure in viral
control. We identified IL-27 as a gp130 cytokine
that promoted antiviral CD4+ T cell accumulation
in vivo and that rapidly induced IL-21 ex vivo.
Furthermore, IL-27R was critical for control of per-
sistent LCMV in vivo. These results reveal that
gp130 cytokines (particularly IL-27) are key regula-
tors of CD4+ T cell responses during an established
chronic viral infection, empowering both humoral
and cytotoxic immunity.
INTRODUCTION
Chronic viral infections such as human immunodeficiency virus-
type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus (HBV)
affect hundreds of millions of people worldwide (Virgin et al.,
2009). Viral persistence is associated with decreased numbers
of both virus specific CD4+ and CD8+ T cells along with a pro-
gressive loss of their ability to kill infected targets and produce
important effector molecules such as interferon-g (IFN-g), tumor
necrosis factor-a (TNF-a), and interleukin-2 (IL-2) (Letvin and
Walker, 2003; Rehermann and Nascimbeni, 2005). Indeed, upre-
gulation of multiple inhibitory surface molecules including PD-1,
LAG-3, and Tim3 (Barber et al., 2006; Blackburn et al., 2009;
Wherry et al., 2007), along with IL-10 (Brooks et al., 2006; Ejrnaes
et al., 2006), during chronic infection contributes to the hierarchi-
cal loss of function seen in virus-specific T cells. In addition,
transforming growth factor-b (TGF-b) signaling limits the
numbers of virus-specific T cells (Boettler et al., 2012; Garidou
et al., 2012; Tinoco et al., 2009). These features appear
commonly among actively replicating chronic viruses in humans548 Immunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc.and other animals (Clerici et al., 1994; Cumont et al., 2007; Day
et al., 2006; Le Clerc et al., 2009; Rigopoulou et al., 2005; Urbani
et al., 2006), and this highly immunosuppressive environment
prevents viral eradication andmakes the host extremely suscep-
tible to secondary infections and cancers.
Individuals control persistent viruses to differing extents,
ranging from elite controllers of HIV-1 and acutely resolving
HCV patients to fast HIV and HCV progressors (Letvin and
Walker, 2003; Rehermann and Nascimbeni, 2005). This varied
degree of viral control associates with different quality and quan-
tity of CD4+ and CD8+ T cell responses (Virgin et al., 2009). In
particular, CD4+ T cells are central for several aspects of antiviral
responses. The outcome of HIV infection depends critically on
the rate and the extent of virus-specific CD4+ T cell expansion
with decreased CD4+ T cell numbers tightly correlating with pro-
gression into AIDS (Porichis and Kaufmann, 2011; Virgin and
Walker, 2010). Similarly, spontaneous recovery from HCV and
HBV infection associates with vigorous CD4+ and CD8+ T cell
responses while CD4+ T cell depleted chimpanzees fail to clear
HBV or HCV and develop severe liver disease (Rehermann and
Nascimbeni, 2005). CD4+ T cells are also essential to control
the persistent variant of lymphocytic choriomeningitis virus,
LCMVClone 13 (Cl13), in amousemodel of chronic viral infection
(Battegay et al., 1994; Matloubian et al., 1994a). Recently, this
model has been used to uncover CD4+-derived IL-21 as vital
for CD8+ (but not CD4+) T cell maintenance during late chronic
infection (Elsaesser et al., 2009; Fro¨hlich et al., 2009; Yi et al.,
2009). IL-21 has also been found to positively correlate with
lower viral loads in HIV- and HCV-infected patients (Chevalier
et al., 2011; Iannello et al., 2010; Yue et al., 2010). In addition,
LCMV Cl13 infection results in the late accumulation of virus-
specific T follicular helper (Tfh) cells (Fahey et al., 2011; Harker
et al., 2011), a process subsequently observed during HBV,
HCV, simian immunodeficiency virus (SIV), and HIV infection
(Feng et al., 2011, 2012; Lindqvist et al., 2012; Petrovas et al.,
2012). This is in part dependent on IL-6 signaling on CD4+
T cells during the later stages of chronic infection and results in
enhanced virus-specific antibody responses and viral control
(Harker et al., 2011; Petrovas et al., 2012).
IL-6 is the archetypal member of the IL-6 cytokine family,
which includes IL-11, IL-27, leukemia inhibitory factor (LIF),
cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M
(OSM) (Silver and Hunter, 2010). The members of the IL-6 family
can exert both unique and overlapping functions through their
common use of the constitutively expressed transmembrane re-
ceptor gp130, which dimerizes with cytokine-specific receptors
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A B Figure 1. GP130 Signaling in T cells Is
Crucial for Control of Chronic LCMV Infec-
tion
WT (C57B/6 or Il6stfl/fl) and Cd4-cre Il6stfl/fl mice
were infected with 2 3 106 pfu of LCMV Cl13 i.v.
Viral load was monitored in the serum throughout
infection (A) and the indicated tissues at day 135
p.i. by immunofocus assay (B). Data is represen-
tative of two experimental repeats; nR 4 mice per
group with mean ± SEM depicted. This figure is
supported by Figure S1.
Immunity
T Cell gp130 Signaling in Chronic Infectionon cytokine binding. Given this conserved signaling pathway, we
speculated that along with IL-6, other members of the IL-6 family
of cytokines may have potent effects on T cell function during
chronic infection. Supporting this, IL-6 deficiency does not affect
in vivo IL-21 during chronic infection; however, ex vivo IL-6 stim-
ulation of CD4+ T cells from LCMV Cl13 infected mice causes
rapid expression of Il21 (Harker et al., 2011), suggesting the
presence of functional redundancies for IL-21 induction.
To bypass such functional redundancies, we examined the
effect of genetic ablation of Il6st (which encodes gp130) in
T cells during persistent LCMV Cl 13 infection in mice. In the
absence of gp130 on T cells, mice were incapable of controlling
infection, had a profound reduction in the numbers of virus-spe-
cific CD8+ and CD4+ T cells, and compromised antibody
responses. In contrast to CD8+ T cells, which appeared function-
ally unaltered by gp130 deficiency, Il6st/CD4+ T cells also had
greatly reduced Tfh proportions and IL-21 production. Although
the CD8+ T cell defects were in most part extrinsic, direct gp130
signaling on CD4+ T cells was essential for their survival and
function at late stages of chronic LCMV infection. We identified
IL-27 as the gp130 signaling cytokine promoting CD4+ T cell sur-
vival and that (similarly to IL-6) was capable of rapidly inducing
IL-21 ex vivo but was redundant for its in vivo production. Our
data indicate that gp130 signaling cytokines play a vital role dur-
ing late stages of chronic viral infection including regulation of
CD4+ T cell survival and IL-21 production to orchestrate antiviral
responses.
RESULTS
Gp130 Signaling on T Cells Was Essential for Control of
Chronic Viral Infection
To investigate the role of T cell-specific gp130 signaling on con-
trol of a chronic viral infection, we infected Cd4-cre Il6stfl/fl
(where Il6st is deleted in CD4+ and CD8+ T cells) or wild-type
(WT) mice with LCMV Cl13. Loss of gp130 signaling did not
adversely affect the proportion of regulatory T (Treg) cells,
CD4+ or CD8+ T cells, or their capacity to produce TNF-a or
IFN-g, in the spleen prior to infection (see Figure S1 available
online). Initial and peak viremia were identical; however, mice
lacking T cell gp130 showed a complete failure to control viremia
while WT mice had significantly reduced viral loads from day 45
postinfection (p.i.) onward (Figure 1A). By day 130 p.i., virus was
readily detectable across multiple tissues in Il6st/mice while it
was only detected in the brain of WT animals (Figure 1B). Gp130
deficiency did not affect the clearance of acute LCMVArmstrongIminfection (data not shown). In contrast to the decline in viremia
that we previously observed in WT and Il6/ mice between
days 30 and 45 p.i., mice deficient in T cell gp130 showed little
or no decline in viremia between these two time points (Figure 1A)
(Harker et al., 2011). These results demonstrated that gp130
signaling on T cells played a critical role in controlling chronic
(but not acute) LCMV infection in vivo. In addition, the fact that
viremia was higher in mice lacking gp130 compared with Il6/
mice suggested that gp130 signaling cytokines (other than
IL-6) significantly contributed to viral containment during chronic
LCMV infection.
T Cell gp130 Signaling Promotes CD8+ and CD4+ T Cell
Accumulation at Late Stages of Chronic Infection
IL-6 deficiency does not affect the total numbers of virus specific
CD8+ or CD4+ T cells throughout chronic LCMV infection (Harker
et al., 2011). In the next series of experiments, we aimed to
identify the immune defects that resulted in the more severe
failure ofCd4-cre Il6stfl/fl mice compared to Il6/mice to control
LCMV Cl13. For that, we first monitored the expansion of virus-
specific CD8+ and CD4+ T cells after infection.
We observed similar numbers of H2-Db LCMV GP276–284 and
H2-Db LCMVGP33–41-specific CD8
+ T cells in blood and spleens
of WT and Cd4-cre Il6stfl/fl animals at day 9 p.i. (Figures 2A and
2B). By day 15 p.i., however, there were significantly fewer
virus-specific CD8+ T cells in the blood of Cd4-cre Il6stfl/fl ani-
mals, a trend that continued until day 60 p.i., the last time point
analyzed (Figure 2A). These findings were confirmed in the
spleen where Cd4-cre Il6stfl/fl mice had significantly fewer
H2-Db LCMV GP33–41 and GP276–284-specific CD8
+ T cells
compared to infection matched controls at day 30 (but not day
9) p.i. (Figure 2B).
‘‘Antigen experienced’’ PD-1+ CD4+ T cells in the blood also
showed normal development in Cd4-cre Il6stfl/fl mice on days 9
and 15 p.i., but a significantly reduced number was seen from
day 30 onward compared to WT mice (Figure 2C). The number
of H2-Ab LCMV GP67–77-specific CD4
+ T cells was also dramat-
ically reduced in the absence of gp130 signaling, with a profound
reduction of virus specific cells observable at day 30 p.i. (16% of
WT numbers), but unaltered numbers at day 9 p.i. (Figure 2D).
Combined these results show that gp130 cytokines, while not
required for priming and initial expansion of virus specific T cell
responses, are essential for their accumulation at late stages
of chronic LCMV infection. Given that neither CD4+ nor CD8+
T cell numbers are affected by the absence of IL-6 alone (Harker
et al., 2011), the aforementioned results highlight a critical role formunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc. 549
0 20 40 60
104
105
106
***
*** *
Days post infection
PD
1+
 C
D
4 
T 
ce
lls
 (#
/m
l
bl
oo
d)
Day 9 Day 30
0
5
10
15
*
6.3 fold
I-A
b  
G
P
67
-7
7+
 C
D
4 
T 
ce
lls
 (x
 1
04
)
A B
C
Day 9 Day 30
0
2
4
6 **
D
b  
LC
M
V 
G
P 3
3-
41
+
C
D
8 
T 
ce
lls
 (x
 1
05
)
C
D
8
H2-Db GP276-284
Day 9
Day 30
Day 9 Day 30
0
2
4
6
8
10 *
D
b  
LC
M
V 
G
P 2
76
-2
84
+
C
D
8+
 T
 c
el
ls
 (x
 1
05
)
0 20 40 60
103
104
105 ***
*** *
wildtype
Cd4-cre Il6stfl/fl
Days post infection
D
b 2
76
-2
84
+  
C
D
8+
 T
 c
el
ls
 (#
/m
l  
bl
oo
d)
D
WT Cd4-cre Il6stfl/fl
C
D
8
H2-Db GP33-41
Day 9
Day 30
Cd4-cre Il6stfl/flWT
Cd4-cre Il6stfl/flWT
Day 9
Day 30
C
D
4
I-Ab GP67-77
Figure 2. T Cell-Specific gp130 Signaling Is
Required for Accumulation of Virus-Specific
CD8 and CD4 T Cells during Chronic LCMV
Infection
WT (C57B/6 or Il6stfl/fl) and Cd4-cre Il6stfl/fl mice
were infected with 2 3 106 pfu of LCMV Cl13 i.v.
(A) PBMCs were analyzed to determine the num-
ber of GP276–284 CD8
+ T cells.
(B) At days 9 and 30 p.i., splenocytes were
analyzed by flow cytometry to determine the
number of H2-Db GP276–284 and GP33–41 CD8
+
T cells.
(C) As in (A), PBMCwere analyzed to determine the
number of PD-1+ CD4+ T cells.
(D) As in (B), I-Ab GP67–77
+ CD4+ T cells numbers
were determined in the spleen, the fold increase
from CD4-cre Il6fl/fl to WT cells at day 30 p.i.
is indicated. Data is representative of three
experimental repeats n R 4 mice per group with
mean ± SEM depicted. This figure is supported by
Figure S2.
Immunity
T Cell gp130 Signaling in Chronic InfectionIL-6 independent gp130 signaling in the maintenance of virus-
specific CD8+ and CD4+ T cell numbers at later stages of chronic
infection.
Gp130 Deletion in T Cells Alters CD4+T Cell Functions at
Late Stages of Chronic Infection
We next investigated the consequences of ablated gp130
signaling on the function of CD8+ and CD4+ T cells. Chronic
infection not only leads to deletion of virus-specific CD8+
T cells but also a hierarchical (IL-2 > TNF-a > IFN-g) loss of func-
tion of those cells that remain (Wherry et al., 2003). The loss of
gp130 signaling on T cells did not, however, alter the level of
functional exhaustion in virus specific CD8+ T cells (Figure S2).
During chronic LCMV infection there is a progressive increase
in the proportion of virus specific CD4+ Tfh cells (Fahey et al.,
2011; Harker et al., 2011). In this context, IL-6 signaling is
required for maximal upregulation of Bcl6 and Tfh cell numbers
but is not required for these cells to produce IL-21 (Harker
et al., 2011), a cytokine vital to the maintenance of virus-specific
CD8+ T cells (Elsaesser et al., 2009; Fro¨hlich et al., 2009; Yi et al.,550 Immunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc.2009). As expected, loss of gp130
signaling resulted in significant loss of
Tfh cell differentiation and Bcl6 expres-
sion in both virus-specific and total
CD4+ T cells at day 30 p.i., although the
expression of Bcl6 within the remaining
CXCR5+ virus-specific CD4+ T cells was
not significantly affected (Figures S3A–
S3C). In contrast to the reduced number
of Tfh cells, the proportion of FoxP3+ T
regulatory cells (Tregs) was increased at
day 30, but not day 9, p.i. in the absence
of gp130 signaling (Figure S3D). How-
ever, the total number of Treg cells was
unaltered in gp130-deficient animals at
both time points studied. Stimulation of
CD4+ T cells from both WT and Cd4-cre
Il6stfl/fl mice at day 9 p.i. with LCMVGP67–77 peptide resulted in moderate IFN-g production and
low IL-21 secretion as previously reported (Figure 3A; Elsaesser
et al., 2009). At day 30 p.i., we observed fewer peptide-respon-
sive IFN-g+ CD4+ T cells, consistent with the reduced number Db
GP67–77
+ CD4+ T cells in Cd4-cre Il6stfl/fl mice. Cd4-cre Il6stfl/fl
IFN-g+ CD4+ T cells also produced significantly less IL-21 than
WTCD4+ T cells after GP67–77 ex vivo peptide stimulation. Similar
observations were seen in response to polyclonal PMA and Ion-
omycin stimulation (Figure 3B). Consistently, Il21 transcripts
were significantly reduced in purified Db GP67–77
+ CD4+ T cells
from Cd4-cre Il6stfl/fl mice compared to WT controls (Figure 3C).
These results indicated that gp130 signaling is not only essential
for CD4+ T cell maintenance and differentiation, but it is also
necessary for them to produce IL-21 at late stages of chronic
LCMV infection. The defective IL-21 production in the absence
of T cell gp130 signaling contrasted with unchanged amounts
observed in Il6/ mice (Harker et al., 2011). This implied the
presence of gp130 cytokines (other than IL-6) that regulated
this fundamental CD4+ T cell function during an established
chronic viral infection.
AB C
Figure 3. T Cell Specific gp130 Signaling Is
Required for IL-21 Production during
Chronic LCMV Infection
WT (C57B/6 or Il6stfl/fl) and Cd4-cre Il6stfl/fl mice
were infected with 2 3 106 pfu of LCMV Cl13 i.v.
(A and B) At days 9 and 30 p.i., splenocytes were
stimulated with (A) LCMV GP67–77 peptide or (B)
PMA and ionomycin and the number of IFN-g
secreting cells (GP67–77-specific only), and the
proportion of IFN-g+ cells that were also secreting
IL-21, were determined by flow cytometry.
(C) At day 30 p.i., CD4+ and I-Ab LCMV GP67–77
+
cells were isolated by flow cytomtery, and Il21
expression, relative to Gapdh, was determined by
qPCR. n.d. = not detectable; data are represen-
tative of three experimental repeats, n R 4 mice
per groupwithmean ± SEMdepicted. This figure is
supported by Figure S3.
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T Cell gp130 Signaling in Chronic InfectionConsistent with defective CD4+ T cell accumulation and func-
tion we observed dramatic effects on humoral immunity in Cd4-
cre Il6stfl/fl compared to WT mice. This included lower numbers
of germinal center B cells, reduced concentrations of LCMV-
specific immunoglobulin (Ig), IgG, IgG1, and IgG2a antibodies
and weakened avidity of LCMV-specific IgG (Figure S4). These
results further demonstrate the need for gp130 signaling in
CD4 T cells for optimal antibody responses.
Cell-Intrinsic gp130 Is Essential for Virus Specific CD4+
T Cells Accumulation and IL-21 Production
The loss of T cell-specific gp130 signaling, although not affecting
T cell development or the initial expansion of either virus-specific
CD4+ or CD8+ T cell responses during LCMV infection, had
significant impact on the number of virus-specific T cells at later
stages of infection (day 30 p.i.) and prevented viral control. To
determine the role of intrinsic gp130 signaling on either CD8+
or CD4+ T cells, we generated mixed WT:Cd4-cre Il6stfl/fl bone
marrow (BM) chimeric mice. Injection of an equal ratio of WT
and Cd4-cre Il6stfl/fl BM cells favored development of WT
T cells, with an approximately 70:30 (WT:Il6st/) ratio of CD8+
and CD4+ T cells at 8 weeks after reconstitution (Figure S5A).
The bias to WT cells seen was similar to that described in mixed
chimeras reconstituted with equal proportions ofWT and Il6ra/
deficient BM cells (Harker et al., 2011) suggesting that IL-6
played a role in the development of T cells under competitive
conditions.
At day 30 after LCMV Cl13 infection, the numbers of H2-Db
LCMVGP33–41 CD8
+ T cells were reduced in the gp130-deficient
compartment versus WT in some, but not all, mixed chimeras,
reaching a p value equal to 0.0649 (Figure 4A). In contrast,
as in Cd4-cre Il6stfl/fl mice, the number of Db GP67–77
+ CD4+
T cells were significantly and consistently reduced in the Il6st/
compared to WT cells, and the total number of gp130-deficient
virus-specific cells was only 3.5% of WT cells in this setting (Fig-Immunity 39, 548–559, Seure 4B). Tfh cell differentiation in the
remaining virus-specific CD4+ T cells,
and total CD4+ T cells, was also dramati-
cally reduced (Figure S5B). Consistently,
there was low or undetectable expressionof Bcl6 in virus-specific CD4+ T cells in the absence of gp130,
whereas Prdm1 (Blimp-1) expression was lower but detectable
(Figure S5C).
Deletion of T cell-specific Il6st during intestinal nematode
infection, in otherwise highly susceptible IL-10-deficient animals,
resulted in enhanced Th2 CD4+ T cell and reduced Th1 and Th17
CD4+ T cell, mediated immunity, and accelerated parasite expul-
sion and protection (Fasnacht et al., 2009). In this study, we saw
slight reductions in the expression of both Tbx21 (T-bet) (Th1)
and Gata3 (Th2) in virus-specific CD4+ T cells in the absence of
Il6st, but no change in the balance of the immune response (Fig-
ures S5E–S5F), whereas we saw little to noRorc expression indi-
cating few or no Th17 cells were present (data not shown). This
difference is most likely as a result of the different infectious sys-
tems used, because this is the first report of the overall role of
T cell-specific gp130 signaling during a viral infection.
The proportion of IFN-g-producing cells that were also pro-
ducing IL-21 was significantly reduced in the absence of
gp130, indicating that cell intrinsic gp130 signaling is required
for IL-21 production after ex vivo peptide stimulation (Figure 4C).
Accordingly, amounts of Il21 transcript measured directly ex vivo
were undetectable in Il6st/ I-Ab GP67–77 CD4
+ T cells from
mixed chimeras, whereas they were readily detectable in their
WT counterparts (Figure 4D). These results indicate that
although CD8+ T cells might be modestly influenced by intrinsic
gp130 signaling, CD4+ T cells are greatly dependent on direct
gp130 signaling to both accumulate and acquire key helper
properties during late chronic LCMV infection.
Direct gp130 Signaling Promotes CD4+ T Cell Survival
during Chronic Viral Infection
To discern whether the reduced numbers of virus-specific CD4+
T cells resulted from increased cell death, reduced proliferation,
or both, we analyzed apoptosis and cell cycle entry in WT versus
Cd4-cre Il6stfl/fl mice 30 days after LCMVCl13 infection. Annexinptember 19, 2013 ª2013 Elsevier Inc. 551
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Figure 4. Cell-Intrinsic gp130 Signaling Is Required for CD4+ T Cell Accumulation and IL-21 Production
Congenic WT (CD45.1) mice were lethally irradiated and reconstituted with a 50:50 mix of CD45.1 and Cd4-cre Il6stfl/fl (CD45.2) bone marrow cells. Eight weeks
later, chimeras were infected with 2 3 106 pfu of LCMV Cl13. At day 30 p.i., the percentages of splenic CD8+ T cells that were H2-Db GP33–41
+ (A) and the
percentage and number of splenic CD4+ T cells that were I-Ab GP67–77
+ (B) in CD45.1+ or CD45.2+ compartments were determined by flow cytometry. The fold
increase between WT and Il6st/ is depicted.
(C) Splenocytes were stimulated ex vivo with GP67–77 peptide and the proportion of IFN-g-producing CD4
+ T cells that were also producing IL-21 was determined
by flow cytometry and (D) Il21 expression determined in I-Ab GP67–77
+ CD4+ T cells by qPCR. n.d. = not detectable. Data are representative of four independent
repeats from pooled samples of nR 4 mice, with mean ± SEM depicted. This figure is supported by Figure S4.
Immunity
T Cell gp130 Signaling in Chronic InfectionV staining revealed that a higher proportion of virus-specific
CD4+ T cells were undergoing apoptosis in Cd4-cre Il6stfl/fl
compared to WT mice; and this difference was further accentu-
ated in the competitive environment generated in WT:Cd4-cre
Il6stfl/fl mixed chimeras (Figures 5A and 5B). These results
were validated by the presence of increased cleaved caspase-
3 in Il6st/ PD1+ CD4+ T cells compared toWT cells, another in-
dicator of increased cell-intrinsic apoptosis (Figure 5C).
In contrast, analysis of bromodeoxyuridine (BrdU) incorpora-
tion revealed that the proliferation of virus-specific CD4 T cells
was enhanced (likely as a result of a compensatory effect) in
Cd4-cre Il6stfl/fl mice, but similar in WT and Il6st/ cells in the
mixed chimeric setting (Figures 5D and 5E). There was a very
low frequency of BrdU+ virus-specific CD4+ T cells at day 30
p.i. in the mixed chimera; however, in the same system WT
PD1+ CD4+ T cells and Il6st/ PD1+ CD4+ T cells showed
detectable, and similar proportions of, Ki67+ cells supporting
the absence of an intrinsic proliferation defect when gp130
signaling is not present (Figure 5F). Overall, these data indicate552 Immunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc.that cell-intrinsic gp130 signaling was fundamental in promoting
CD4+ T cell survival at late stages of chronic LCMV infection.
IL-27 Drives Accumulation of Virus-Specific CD4+ T
Cells and Promotes IL-21 Production Ex Vivo
To determinewhich of the cytokines that use gp130was involved
in promoting CD4+ T cell survival and IL-21 production, we
examined their individual capacity to phosphorylate the down-
stream molecules STAT-1 and STAT-3. In CD4+ T cells taken
from naive animals IL-6, IL-27, OSM, and LIF were all capable
of STAT-3 phosphorylation, while IL-6 and IL-27 also caused
phosphorylation of STAT-1 (Figure 6A). As we have shown previ-
ously, ex vivo IL-6 stimulation of transgenic LCMV GP61–80-spe-
cific CD4+ T (Smarta) cells taken from WT mice 18 days after
LCMV Cl13 infection also caused rapid phosphorylation of
STAT-3 (Figure 6A) (Harker et al., 2011). However, IL-6 stimula-
tion of Smarta cells did not promote STAT-1 phosphorylation.
In comparison, IL-27 stimulation of the same Smarta cells
caused slightly weaker phosphorylation of STAT-3, but
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Figure 5. Virus-Specific CD4+ T Cells Exhibit an Intrinsic Survival Defect in the Absence of gp130 Signaling
WT, Cd4-cre Il6stfl/fl.
(A and D) orWT:Cd4-cre Il6stfl/fl mixed chimeric (B, C, E, and F) mice were infectedwith 23 106 pfu of LCMVCl13 i.v. and splenocytes analyzed by flow cytometry
at day 30 p.i.
(A and B) The percentage of Annexin V binding in I-Ab GP67–77
+ CD4+ T cells was determined.
(C) The percentage of PD1+ CD4+ T cells expressing cleaved Caspase-3+ was determined.
(D and E) The proportion of I-Ab GP67–77
+ CD4+ T cells that had incorporated BrdU was quantified.
(F) The proportion of Ki67+ was analyzed within PD1+ CD4+ T cells. Data are representative of two or three independent experiments of n% 4mice per group, with
mean ± SEM depicted. This figure is supported by Figure S5.
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11, and OSM phosphorylated neither STAT-1 nor STAT-3.
Because IL-27 was the only tested member of the IL-6 family
of cytokines, other than IL-6, capable of directly signaling on
virus-specific CD4+ T cells during LCMV Cl13 infection, we eval-
uated its cell-intrinsic effects on CD4+ T cells in vivo. In
WT:Il27ra/ mixed bone marrow chimeras, unlike Cd4-cre
Il6stfl/f and Il6ra/ mixed bone marrow chimeras, the Il27ra/
CD4+ T cell compartment was similar in proportion to the WT
CD4+ T cell compartment after reconstitution (Figure S6A). There
was, however, a slight bias toward WT CD8 T cells and Il27ra/
B cells during reconstitution, which could indicate a role for IL-27
during lymphocyte development (Figure S6A). After LCMV Cl13
infection, direct IL-27 signaling on CD4+ T cells was vital for
the accumulation of virus specific CD4+ T cells, indicated by
the reduced proportion of I-Ab GP67–77
+ CD4+ T cells in the
Il27ra/ compared to the WT compartment, as was seen in
Cd4-cre Il6stfl/fl mice (Figure 6B). However, IL-21 production inImthe remaining Il27ra/ virus-specific CD4+ T cells was similar
to that seen in WT CD4+ T cells (Figure 6C) as was the proportion
of virus-specific CD4 T cells that expressed Bcl6 and differenti-
ated into Tfh cells (Figures S6B and S6C).
Stimulation of polyclonal virus-specific PD-1+ CD4+ T cells
taken 18 days after LCMV Cl13 infection with recombinant
IL-27 resulted in rapid upregulation of Il21, with the amount of
transcript peaking at 6 hr after stimulation, whereas as we
have previously shown, IL-6 also caused the upregulation of
Il21 transcript, but this peaked at 12 hr after stimulation (Fig-
ure 6D). Increased Il21 transcript was also seen 6 hr after IL-27
stimulation in Smarta CD4+ T cells (Figure 6E). Ex vivo IL-27 stim-
ulation also lead to upregulation of Bcl6 expression in PD-1+ and
Smarta CD4+ T cells (Figures S6D and S6E). Together, these
data show that IL-27 plays an essential role in the accumulation
of virus-specific CD4+ T cells at late stages during chronic viral
infections. Furthermore, both IL-27 and IL-6 were capable of
rapidly upregulating IL-21 in virus-specific CD4+ T cells butmunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc. 553
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Figure 6. IL-27 Signaling on Virus-Specific
CD4+ T Cells Is Vital for Their Accumulation
during Chronic Viral Infection
(A) LCMV-specific CD45.1+ transgenic CD4+
T cells (Smarta) were transferred i.v. 1 day prior to
LCMV Cl13 infection, and splenocytes were iso-
lated at 18 days p.i. The amount of pSTAT1 and
pSTAT3were then determined in naive and Smarta
CD4+ T cells 30 min after ex vivo stimulation with
50 ng/ml of the indicated recombinant cytokines
by flow cytometry.
(B and C) WT:Il27ra/ mixed bone marrow chi-
meras were generated and infected with LCMV
Cl13. 30 days p.i., the proportion of splenic CD4+
T cells that were I-Ab Gp67–77
+ (B) and CD4+ T cells
that were IFN-g+ IL-21+ after GP67–77 peptide
stimulation (C) were determined by flow cy-
tometry.
(D and E) At day 18 after LCMV Cl13 infection,
PD1+ CD4+ T cells (D) or Smarta cells (E) prepared
as in (A) were isolated by flow cytometry. Expres-
sion of Il21 relative to Gapdh was determined 6,
12, and 24 hr (D) or 6 hr (E) after ex vivo stimulation
with IL-6, IL-27, or PBS. (A) is representative of two
independent experiments with pools of five mice
per group. (B), (C), and (D) and (E) are represen-
tative of five, three, and two independent experi-
ments, respectively, with mean ± SEM depicted.
This figure is supported by Figure S6.
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T Cell gp130 Signaling in Chronic Infectionwere redundant for its production in vivo, where IL-21 production
could only be reduced by removal of IL-6 and IL-27 common
coreceptor, gp130.554 Immunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc.We next quantified the number of virus-
specific CD4+ T cells in the spleens of WT
versus Il27ra/nonchimericmice at days
9 and 30 after infection (Figure 7A). We
observedhigher percentageandnumbers
of virus-specific CD4+ T cells in Il27ra/
compared to WT mice at day 9 p.i.
Because this early increase in the CD4+
T cell responses was not observed in
Cd4-cre Il6stfl/fl mice (Figure 2D), it may
result from CD4+ T cell-extrinsic effects
due to lack of IL-27R signaling in other
cell populations. Il27ra/ mice showed
a significant decline in the proportion
and numbers of LCMV-specific CD4+
T cells from day 9 to day 30 p.i., whereas
in WT mice the number of LCMV-specific
CD4+ T cells was maintained or slightly
increased. This defect in anti-viral CD4+
T cells maintenance in Il27ra/ mice
was comparable with the one observed
in Cd4-cre Il6stfl/fl mice and was also
detected in blood samples, where the
number of PD1+CD4+ T cells was signifi-
cantly lower at day 45 p.i (Figures 7B
and 7C, respectively). These results were
consistent with our conclusions from
Cd4-cre Il6stfl/fl mice, WT:Cd4-cre Il6stfl/fland WT:Il27ra/ mixed chimeras that cell-intrinsic IL-27R and
gp130 signaling promotes the maintenance of virus-specific
CD4+ T cell numbers at late stages of chronic viral infection.
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Figure 7. IL-27 Is Critical in Controlling Viral Load during Chronic LCMV Infection
WT or Il27ra/ animals were infected with LCMV Cl13.
(A and B) Splenic I-Ab GP67–77
+ CD4+ T cells at days 9 and 30 p.i. were enumerated by flow cytometry (A). Example flow plots are shown and the proportion of Db
GP67–77
+ CD4+ T cells at day 30 p.i. relative to day 9 p.i. was compared to that observed in Cd4-cre Il6stfl/fl animals (B).
(C) PD-1+ CD4+ T cells were enumerated in the blood by flow cytometry.
(D and E) Viral load was determined in the blood (D) at various time points and in tissues (E) at day 130 after infection. Data is representative of n = 2 experimental
repeats of n = 5 mice per group, with mean ± SEM depicted.
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T Cell gp130 Signaling in Chronic InfectionFinally, we assessed the importance of IL-27R signaling in
overall viral control. Il27ra/ mice exhibited significantly higher
viremia than their WT counterparts as early as between days 5
and 9 p.i. (Figure 7D). Given that deletion of Il6st exclusively in
T cells did not affect early control of LCMV Cl13 (Figure 1A), it
is likely that this initial difference in viral loads is a consequence
of deficient IL-27 signaling in non-T cells. Infection of Il27ra/
mice also resulted in a failure of the long term control of persis-
tent LCMV with virus detectable in the blood and a range of
tissues up to 130 days after infection, when the majority of WT
animals had cleared virus (Figure 7D and 7E). Altogether, these
data indicate that IL-27 signaling plays a critical role in the main-
tenance of CD4+ T cell numbers and viral control during chronic
viral infection in vivo.
DISCUSSION
The presence and function of antigen-specific CD4+ T cells is
vital for optimal immune responses in many infectious contexts,
but especially during chronic viral infections. Here we showed
that direct gp130 signaling was vital for the survival of virus-spe-
cific CD4+ T cells and for their key functional properties such as
IL-21 production during chronic viral infection in vivo. Further, we
demonstrated that different members of the IL-6 family have
both unique and redundant roles in this process; IL-27 wasImessential for CD4+ T cell accumulation, while we have previously
shown that IL-6 plays a dominant role in the differentiation of Tfh
cells. On the other hand, although both IL-6 and IL-27 were
capable of promoting IL-21 production ex vivo they were redun-
dant in vivo, suggesting that multiple gp130 signaling cytokines
secure optimal IL-21 production.
Higher concentrations of IL-21 are associated with lower viral
loads in HIV and HCV infections (Chevalier et al., 2011; Iannello
et al., 2010; Yue et al., 2010) and with an increased success
rate in vaccination of chronically infected individuals (Pallikkuth
et al., 2011). STAT-3 is heavily associated with the transcription
of Il21 (Kaplan et al., 2011). Engagement of gp130 with cytokine-
specific receptors results in rapid phosphorylation of STAT-3
(Ernst and Jenkins, 2004) and our study revealed a vital role for
gp130 signaling in IL-21 production in vivo at late stages of
chronic LCMV infection. STAT-3 binds not only at the ll21 pro-
moter but also atBatf andMaf loci (Durant et al., 2010), two other
transcription factors known to promote IL-21 (Hiramatsu et al.,
2010; Schraml et al., 2009), suggesting multiple molecular path-
ways through which gp130 signaling might trigger and maintain
IL-21 production. Once produced, IL-21 itself could act in an
autocrine fashion by further phosphorylating STAT-3. Both IL-6
and IL-27, were capable of inducing STAT-3 phosphorylation
and Il21 transcription in virus-specific CD4+ T cells taken from
chronically infected mice but none of the other gp130 cytokinesmunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc. 555
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T Cell gp130 Signaling in Chronic Infectiontested (i.e., IL-11, OSM, and LIF) were capable of phosphory-
lating STAT-3 in LCMV-specific CD4+ T cells. Given the essential
nature of gp130 but nonessential roles for IL-6R or IL-27R, our
data strongly suggests that IL-6 and IL-27 act redundantly to
promote IL-21 production in CD4+ T cells. Although our study
focused on chronic viral infection, it is conceivable that gp130
signaling may trigger IL-21 production in the context of auto-
immune diseases such as diabetes, multiple sclerosis, and
Sjogren’s syndrome where IL-21 is associated with increased
pathology (Jones et al., 2009; McGuire et al., 2011; Spolski
et al., 2008).
IL-27-gp130 signaling promoted the survival of virus-specific
CD4+ T cells at late stages of chronic LCMV infection. However,
it was dispensable for CD4+ T cell accumulation early after infec-
tion, indicating that other signaling pathwaysmust be involved in
inducing CD4+ T cell proliferation and survival at these time
points. Likely candidates are the common gc cytokines such
as IL-2, IL-7, and IL-15, which are potent mediators of both naive
and activated T cell survival and proliferation (Rochman et al.,
2009). Indeed provision of either IL-2 or IL-7 is sufficient to
rescue mice from LCMV Cl13 infection (Blattman et al., 2003;
Pellegrini et al., 2011). Many of their effects are mediated by
activation of STAT-5, which also blocks the differentiation of
Tfh cells (Johnston et al., 2012; Nurieva et al., 2012). Tfh cells
accumulate in LCMV Cl13 infected mice during late stages of
infection, at a time when IL-2 production is compromised by
T cell exhaustion (Brooks et al., 2005), which may indicate
reduced gc-STAT5 signaling, leaving CD4+ T cells reliant on
gp130 signaling for survival. In CD8+ T cells, although STAT-3
is not required for initial expansion, it is essential for the forma-
tion of long-lived memory cells, providing evidence that T cells
can progressively alter their STAT requirements for accumula-
tion and survival (Cui et al., 2011). Both IL-6 and IL-21 can phos-
phorylate STAT-3, however, whereas only IL-27 signaling results
in enhanced CD4+ T cell survival in vivo. Meanwhile, only IL-27
phosphorylated STAT-1 in virus-specific CD4+ T cells, suggest-
ing that STAT-1 could promote CD4+ T cell survival late during
chronic infection. Phosphorylation of STAT-1 by IL-27 in this
context is most likely due to its use of WSX-1, which contains
a box 1 janus kinase (JAK) domain capable of activating the
STAT family independently of gp130 (Sprecher et al., 1998). In
many contexts, STAT-1 is thought to activate an antiproliferative,
proapoptotic pathway in T cells (Bromberg et al., 1996; Gil et al.,
2006; Tanabe et al., 2005); thus, exploration of STAT-1’s func-
tions at late stages of infection is worthy of further investigation.
IL-27 is also known to phosphorylate STAT-4 and STAT-5,
although less potently than it does STAT-1, both of which have
potent effects on CD4+ T cell differentiation and could have pro-
survival effects via these pathways (Kaplan, 2005; Lucas et al.,
2003).
The loss of IL-27R signaling across the whole mouse resulted
in reduced viral control and a slight increase in the number of
virus-specific CD4+ T cells at early stages of viral infection.
Because this was not observed when Il6st was conditionally
ablated in T cells, nor in mixed chimeras generated from either
Il27ra/ or Cd4-cre Il6stfl/fl mice, it suggests that IL-27 signaling
also has a vital non-T cell role in antiviral immunity early during
LCMV Cl13 infection. Fitting with this, effective IL-27 signaling
has also been shown in natural killer cells, NK T cells, B cells,556 Immunity 39, 548–559, September 19, 2013 ª2013 Elsevier Inc.and macrophages (Imamichi et al., 2008; Villarino et al., 2005;
Yoshimoto et al., 2004); however, the effects of IL-27 signaling
on cells other than CD4+ T cells during chronic viral infection is
yet to be explored. It is possible that the presence of higher viral
loads early during LCMV Cl13 infection plays a role in the
increased virus-specific CD4+ T cell numbers observed in
LCMV Cl13 infected Il27ra/ mice at day 9 p.i. Alternatively,
this could be a consequence of IL-27’s regulation of cell pop-
ulations that directly influence CD4+ T cell expansion (e.g., anti-
gen-presenting cells). Our data therefore not only show the
importance of IL-27 in the maintenance of virus-specific CD4+
T cell responses and viral control during chronic viral infection
in vivo but also highlight the complex and significant role that
IL-27 plays in different aspects of immune responses and the
need to use models that allow discrimination of cell-intrinsic
versus -extrinsic effects (such as mixed bone marrow chimeras)
in the exploration of these processes.
IL-27 signaling has previously been implicated in controlling
Tfh cells numbers after vaccination (Batten et al., 2010), whereas
we have previously observed that IL-6 plays an essential role in
Tfh cells differentiation during chronic viral infection (Harker
et al., 2011). In this context, IL-27 appears to be essential for
the survival of virus-specific CD4+ T cells, the majority of which
are Tfh cells, but does not appear to control Tfh cell differentia-
tion or Bcl6 expression. Complete loss of gp130-mediated
signaling, however, results in loss of both virus-specific CD4+
T cells and Tfh cell differentiation. This leads us to hypothesize
that during chronic viral infection, IL-6 is vital for Tfh cell differen-
tiation, whereas IL-27 is required for their ongoing survival.
The number of CD8+ and CD4+ T cells is critical in determining
the outcome of chronic viral infections in mice and humans (Re-
hermann and Nascimbeni, 2005; Virgin and Walker, 2010; Virgin
et al., 2009). CD4+ T cells are often not required for the initial gen-
eration of virus-specific CD8+ T cell responses, but they are vital
for themaintenance and quality of these cells and are also funda-
mental for B cell responses (Matloubian et al., 1994b; Shedlock
and Shen, 2003). Notably, the use of vaccines that target both
the cytotoxic and humoral arms of the immune system, such
as the RV144 prime-boost HIV vaccine trial (Benmira et al.,
2010), have demonstrated the efficacy of this approach
compared to prior vaccines that aimed to target a single aspect
of immunity. Our data places gp130 signaling at the center of
CD4+ T cell responses within the highly immunosuppressive
environment of an established chronic viral infection and high-
lights the potential of this pathway as a target for simultaneously
empowering both humoral and cellular immunity in this context.EXPERIMENTAL PROCEDURES
Mice and Viral Stocks
WT C57BL/6 mice, C57BL/6 CD45.1+ mice, and Il27ra/ mice were pur-
chased from The Jackson Laboratory. Cd4-cre Il6stfl/fl mice were kindly pro-
vided by Dr. Werner Mueller (University of Manchester, UK). Mice were bred
and maintained in a closed breeding facility, and mouse handling conformed
to the requirements of the National Institutes of Health (NIH) and the Institu-
tional Animal Care and Use Guidelines of UCSD. Unless otherwise stated, 6-
to 8-week-old mice were infected intravenously (i.v.) with 2 3 106 pfu of
LCMV ARM or Cl13. Viruses were grown, identified, and quantified as
described in (Ahmed et al., 1984; Borrow et al., 1995). For viral quantification
by focus forming, assay vero cells (ATCC) were seeded in 96 well plates and
Immunity
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were then fixed with 1% paraformaldehyde for 30 min, blocked with PBS con-
taining 10% FBS for 1 hr, and incubated with supernatant from 113 hybridoma
cells (Amouse B cell hybridoma producingmonoclonal IgG1 against LCMVNP
kindly provided by M.B. Oldstone, TSRI) for 1 hr. Finally, the cells were incu-
bated with a Cy3 conjugated goat anti-mouse IgG (Jackson Immunoresearch)
for 40 min and foci counted by fluorescent microscope.
Generation of BM Chimeras
BMchimeras were generated via transfer of a 50:50 ratio of BM cells fromCd4-
cre Il6stfl/fl or Il27ra/mice and C57BL/6 CD45.1+ mice into lethally irradiated
C57BL/6 CD45.1+ as described previously (Harker et al., 2011).
LCMV-Specific Antibody ELISAs
LCMV-specific ELISAs and avidity assays were done as we and others have
previously described (Hammond et al., 1997; Harker et al., 2011).
Flow Cytometry
Flow cytometry was done as previously described (Tinoco et al., 2009). The
following fluorochrome labeled antibodies purchased from ebioscience or
BD biosciences were used to stain blood or spleen cells: anti-CD8-pacific
blue, -CD4-pacific blue, -CD19-PE, -CD38-Alexa Fluor 700, -GL7-FITC,
-PD1-PE-Cy7, -ICOS-PE, -SLAM-FITC or PE-Cy7, -CD45.2-APC-Cy7,
-CD45.1-PerCy5.5, -CD200-PerCP-eFlour 610, -IFN-g-APC, -TNF-a-
FITC, -IL-2-PE, -CD107a-FITC, -CD107b-FITC, Annexin-V-PE, and -B220-
FITC. CXCR5, FoxP3, and Bcl6 (BD, K112-91) staining were done as
previously described (Harker et al., 2011). Cells were acquired by using the
Digital LSR II flow cytometer (Becton Dickinson, San Jose, CA). To quantify
incorporation of BrdU by tetramer+ T cells, we injected mice with 2 mg of
BrdU (Sigma-Aldrich) 16 hr before analysis and splenocytes stained with
BrdU Flow kit (BD Biosciences) following the manufacturer instructions.
Staining for fluorescence assisted cell sorting was conducted in an identical
fashion and cells were isolated on a FACSAria (Becton Dickinson, San Jose,
CA) to >95% purify. Flow cytometric data were analyzed with FlowJo soft-
ware (TreeStar, CA).
Ex Vivo T Cell Stimulation
For MHC class-I-restricted GP33–41 peptide (2 mg/ml) or MHC class-II
restricted GP67–77 (5 mg/ml) stimulation and staining were carried out as we
have previously described (Tinoco et al., 2009). For polyclonal stimulation,
we used PMA (10 ng/ml) and ionomicyn (0.5 mg/ml) in place of peptide. For
intracellular IL-21 staining, cells were permeabilized with saponin and incu-
bated with 1:25 dilution of IL-21RhFc (R&D Systems) for 30 min at 4C,
washed twice and stained with 1:200 anti-human Fc-PE (BD PharMingen).
For phosphorylation of STATs, 1,000 CD45.1+ Smarta CD4+ T cells were
transferred i.v. 1 day prior to infection with 2 3 106 pfu of LCMV Cl13. At
18 days p.i., splenocytes were isolated, rested, for 2 hr at 37C, and stimu-
lated with 50 ng/ml of recombinant human IL-6 (National Cancer Institute) or
mouse IL-11, IL-27, LIF (eBioscience), or oncostatin M (Cell Signaling). Cells
were fixed after 30 min, and pSTAT staining was done according to manufac-
turer’s instructions (BD).
Real-Time RT-PCR
Total RNA was extracted from splenocytes by using RNeasy kits (QIAGEN),
and reverse transcribed into cDNA by using superscript III RT (Invitrogen).
cDNA quantification was performed by using SYBR Green PCR kits (Applied
Biosystems) and a real-time PCR Detection System (ABI). Primers for the
genes assessed are described in (Harker et al., 2011). Il21 detection of IL-27
and IL-6 stimulated CD4+ T cells was carried out on 50,000 PD1+ CD4+
T cells and 10,000 Smarta cells per time point, resulting in Il21 detection being
18-fold more sensitive in PD1+ CD4+ T cells compared to Smarta based on
Gapdh expression.
Statistical Analysis
Unpaired Student’s t tests or ANOVA tests were performed by using the InStat
3.0 software (GraphPad, CA). For mixed chimeras, paired t tests were used.
* p < 0.05, ** p < 0.01, *** p < 0.001 in all data shown.ImSUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at http://dx.doi.org/10.1016/j.immuni.2013.08.010.
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